| 000 | 01882 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515165532.0 | ||
| 264 | 0 | _c20090514 | |
| 008 | 200905s 0 0 eng d | ||
| 022 | _a1097-6744 | ||
| 024 | 7 |
_a10.1016/j.ahj.2009.02.012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPrice, Matthew J | |
| 245 | 0 | 0 |
_aEvaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trial. _h[electronic resource] |
| 260 |
_bAmerican heart journal _cMay 2009 |
||
| 300 |
_a818-24, 824.e1 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aClopidogrel |
| 650 | 0 | 4 | _aCoronary Angiography |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug-Eluting Stents |
| 650 | 0 | 4 | _aElectrocardiography |
| 650 | 0 | 4 |
_aGraft Occlusion, Vascular _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocardial Ischemia _xblood |
| 650 | 0 | 4 |
_aMyocardial Revascularization _xmethods |
| 650 | 0 | 4 |
_aPlatelet Activation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aPostoperative Care _xmethods |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aTiclopidine _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBerger, Peter B | |
| 700 | 1 | _aAngiolillo, Dominick J | |
| 700 | 1 | _aTeirstein, Paul S | |
| 700 | 1 | _aTanguay, Jean-François | |
| 700 | 1 | _aKandzari, David E | |
| 700 | 1 | _aCannon, Christopher P | |
| 700 | 1 | _aTopol, Eric J | |
| 773 | 0 |
_tAmerican heart journal _gvol. 157 _gno. 5 _gp. 818-24, 824.e1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ahj.2009.02.012 _zAvailable from publisher's website |
| 999 |
_c18807795 _d18807795 |
||